You can now submit reviews for your favorite Tocris products. Your review will help other researchers decide on the best products for their research. Why not submit a review today?!Submit Review
ICI 215,001 hydrochloride
Discontinued ProductICI 215,001 hydrochloride (Cat. No. 0929) has been withdrawn from sale for commercial reasons.
The active metabolite of ZD 7114 (Cat. No. 0930).
Sold with the permission of AstraZeneca UK Ltd.
|Storage||Store at RT|
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
References are publications that support the biological activity of the product.
How (1993) β3Adrenergic agonists. Drugs Future 18 529
View Related Products by Product Action
Keywords: ICI 215,001 hydrochloride, ICI 215,001 hydrochloride supplier, β3-adrenoceptor, b3-adrenoceptor, β3-adrenergic, b3-adrenergic, agonists, Receptors, ICI215001, hydrochloride, AstraZeneca, Adrenergic, Beta-3, 0929, Tocris Bioscience
2 Citations for ICI 215,001 hydrochloride
Citations are publications that use Tocris products. Selected citations for ICI 215,001 hydrochloride include:
Suárez et al (2014) Oleoylethanolamide enhances β-adrenergic-mediated thermogenesis and white-to-brown adipocyte phenotype in epididymal white adipose tissue in rat. Dis Model Mech 7 129 PMID: 24159189
Littmann et al (2015) Recruitment of β-arrestin 1 and 2 to the β2-adrenoceptor: analysis of 65 ligands. PLoS One 355 183 PMID: 26306764
Reviews for ICI 215,001 hydrochloride
There are currently no reviews for this product. Be the first to review ICI 215,001 hydrochloride and earn rewards!
Have you used ICI 215,001 hydrochloride?
Submit a review and receive an Amazon gift card.
$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image
$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
Literature in this Area
Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* or download your copy today!
*Please note that Tocris will only send literature to established scientific business / institute addresses.
Major depressive disorder is characterized by depressed mood and a loss of interest and/or pleasure. Updated in 2015 this poster highlights presynaptic and postsynaptic targets for the potential treatment of major depressive disorder, as well as outlining the pharmacology of currently approved antidepressant drugs.